Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wehling

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Drugs & Aging|December 20, 2013
Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderlyAlexandra M Kuhn-Thiel, Christel Weiß, Martin Wehling, et al.
Archives of Gerontology and Geriatrics|August 14, 2020
The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adultsFarhad Pazan, Yana Gercke, Christel Weiss, et al.
Drugs & Aging|August 23, 2019
The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older PeopleAndree Rabenberg, Timo Schulte, Helmut Hildebrandt, et al.
Journal of the American Medical Directors Association|September 23, 2019
The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older AdultsFarhad Pazan, Yana Gercke, Christel Weiss, et al.
Seminars in Thrombosis and Hemostasis|September 9, 2005
Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100Martin Feuring, Armin Schultz, Ralf Losel, et al.
Steroids|October 16, 2012
In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1Christian Albrecht, Volker Huck, Martin Wehling, et al.
European Journal of Clinical Pharmacology|August 17, 2014
Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled studyCarina Michalek, Martin Wehling, Jeanina Schlitzer, et al.
FEBS Letters|July 15, 2004
Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84Sabine Braun, Ralf Lösel, Martin Wehling, et al.
European Geriatric Medicine|April 19, 2023
Medication optimization according to the Fit fOR The Aged (FORTA) rules improves functional status in patients hospitalized for geriatric rehabilitationFarhad Pazan, Martin Wehling, Christel Weiss, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.
Drugs & Aging|December 20, 2013
Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderlyAlexandra M Kuhn-Thiel, Christel Weiß, Martin Wehling, et al.
Archives of Gerontology and Geriatrics|August 14, 2020
The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adultsFarhad Pazan, Yana Gercke, Christel Weiss, et al.
Drugs & Aging|August 23, 2019
The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older PeopleAndree Rabenberg, Timo Schulte, Helmut Hildebrandt, et al.
Journal of the American Medical Directors Association|September 23, 2019
The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older AdultsFarhad Pazan, Yana Gercke, Christel Weiss, et al.
Seminars in Thrombosis and Hemostasis|September 9, 2005
Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100Martin Feuring, Armin Schultz, Ralf Losel, et al.
Steroids|October 16, 2012
In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1Christian Albrecht, Volker Huck, Martin Wehling, et al.
European Journal of Clinical Pharmacology|August 17, 2014
Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled studyCarina Michalek, Martin Wehling, Jeanina Schlitzer, et al.
FEBS Letters|July 15, 2004
Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84Sabine Braun, Ralf Lösel, Martin Wehling, et al.
European Geriatric Medicine|April 19, 2023
Medication optimization according to the Fit fOR The Aged (FORTA) rules improves functional status in patients hospitalized for geriatric rehabilitationFarhad Pazan, Martin Wehling, Christel Weiss, et al.
Pageof 17